Active Comparator, Euvichol®-Plus — Competitive Intelligence Brief

Active Comparator, Euvichol®-Plus (Active Comparator, Euvichol®-Plus) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Oral inactivated cholera vaccine. Area: Infectious Disease / Immunology.

phase 3 Oral inactivated cholera vaccine Vibrio cholerae O1 and O139 antigens Infectious Disease / Immunology Biologic

Target snapshot

Active Comparator, Euvichol®-Plus (Active Comparator, Euvichol®-Plus) — International Vaccine Institute. Euvichol-Plus is an oral cholera vaccine that stimulates immune responses against Vibrio cholerae to prevent cholera infection.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Active Comparator, Euvichol®-Plus TARGET	Active Comparator, Euvichol®-Plus	International Vaccine Institute	phase 3	Oral inactivated cholera vaccine	Vibrio cholerae O1 and O139 antigens
Shanchol vaccine	Shanchol vaccine	International Centre for Diarrhoeal Disease Research, Bangladesh	phase 3	Oral inactivated vaccine	Vibrio cholerae O1 and O139 antigens; cholera toxin B subunit

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Oral inactivated cholera vaccine class)

1. International Vaccine Institute · 1 drug in this class